Skip to content
MARKETS / NASDAQ / EYE
NASDAQ · OPHTHALMIC GOODS · LARGE CAP

National Vision Holdings, Inc. EYE

11 fiscal years on record · USD · FY2025 reported · SEC filings only
$2.0B
▲ 9.0% YoY
$29.6M
$73.5M
▲ 92.6% YoY
In brief

What this company does

Within its store brands, National Vision primarily offers two products and one service: eyeglasses, contact lenses and eye exams. As of January 3, 2026, it reached customers through a portfolio of 1,250 retail stores across four brands, its associated omni-channel consumer websites, and its dedicated e-commerce consumer website, DiscountContacts.com. As of January 3, 2026, it had 13,138 full-time and part-time associates, including 635 directly employed optometrists. It operates under one reportable segment, its Owned & Host segment, which includes its two owned brands, America's Best Contacts and Eyeglasses and Eyeglass World, as well as its Host brands, Vista Optical locations within select Fred Meyer stores and Vista Optical locations on select military bases. Its 122 Eyeglass World locations offer eye exams provided by optometrists employed either by the company or by independent professional corporations or similar entities, and have on-site laboratories that enable stores to fulfill certain customer orders and make repairs on site. It has two Host brands, consisting of 53 Vista Optical locations on military bases and 18 Vista Optical locations within select Fred Meyer stores as of January 3, 2026.

Written from the business description in National Vision Holdings, Inc.'s annual report to the U.S. Securities and Exchange Commission, filed 4 March 2026. Every sentence was checked against that document before publication.

Growth
USD 2.0B
Revenue, FY2025 · full 11-year series below
Revenue $B Net income $B
FY2025 · Revenue 2.0 · Net income 0.0
0.8B1.6B201520172019202120232025
Compound annual growth
+6.5%
+3.0%
+6.5%
−11.1%
−4.0%
+23.4%
−10.7%
−3.4%
+20.0%
3 yrs
5 yrs
10 yrs
15 yrs

Revenue compounded at +3.0% a year over five years.

Compound annual rates per period — left blank where that exact year isn't on file, the series crosses a loss, or (per-share rows) a split falls inside the window.

Profitability
1 cents
of every revenue dollar became profit
Operating margin Net margin
FY2025 · Operating 3.0% · Net 1.5%
5%-1%-2%-3%201520172019202120232025
ROE
FY2025 · ROE 3.5%
5%10%-2%-4%-6%201520172019202120232025

Each USD of equity produced 4 cents of profit this year.

Cash & shareholders
returned in FY2025 · dividends + net buybacks
Free cash flow $M
FY2025 · FCF 73.5
80M160M201520172019202120232025
Net buybacks $M Dividends $M
FY2025 · Dividends — · Net buybacks -0.2
80M160M-200MDividendsNet buybacks201520172019202120232025

Total assetsUSD 2.0B
EquityUSD 869.5M
CashUSD 38.7M
Gross debtUSD 236.5M
Net debtUSD 197.8M
Current ratio0.55×

Net debt stands at 23% of equity.

The 11-year record
11 fiscal years
Every figure from documents filed with the SEC · USD
row low → row highnegative
Metric 20252024202320222021202020192018201720162015
Revenue $B2.01.81.81.62.11.71.71.51.41.21.1
Operating income $B0.1−0.00.00.10.20.10.10.00.10.10.0
EBITDA $B········0.10.10.1
Income tax $B0.00.00.00.00.00.0−0.0−0.0−0.00.00.0
Net income $B0.0−0.0−0.10.00.10.00.00.00.00.00.0
Free cash flow $B0.10.00.10.00.20.20.10.0−0.00.00.0
EPS, diluted $0.37−0.36−0.840.521.430.440.400.300.700.230.06
Dividend / sh $···········
Payout %······0039604027
ROE %3.5−3.5−7.64.614.04.34.33.48.23.40.9
Shares out B0.080.080.080.080.080.080.080.080.070.06·

Slide the table for earlier years · "·" marks a figure not available in our data for that year.

Provenance
Company facts, as filed
How we verify · 0 failures in 42 reconciliationsAUDITED

Reconciled in 11 of 19 fiscal years. 51 checks could not be computed.

EPS recomputationBalance-sheet identityGross profitBalance-sheet liquiditymoeda_consistente0 failures
ActivityOphthalmic Goods
Listed onNASDAQ
Incorporated inDelaware
Fiscal year endsJanuary 2
Data on record since2015

Share this section

Download image